Posted by Michael Wonder on 02 Mar 2023
Boomerang Medical earns FDA breakthrough device designation
1 March 2023 - Boomerang Medical is currently enrolling a clinical trial studying a bioelectronic device for people living with Crohn’s disease and ulcerative colitis, the two most common forms of inflammatory bowel disease.
Boomerang Medical has been granted breakthrough device designation from the FDA for its bioelectronic technology targeting the treatment of inflammatory bowel disease.
